About: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Angermann Christiane, Teerlink John, Collins Sean, Kosiborod Mikhail, Biegus Jan, Ferreira João Pedro, Nassif Michael, Psotka Mitchell, Tromp Jasper, Borleffs C. Jan Willem, Ma Changsheng, Comin-Colet Joseph, Fu Michael, Janssens Stefan, Kiss Robert, Mentz Robert, Sakata Yasushi, Schirmer Henrik, Schou Morten, Schulze P. Christian, Spinarova Lenka, Volterrani Maurizio, Wranicz Jerzy, Zeymer Uwe, Zieroth Shelley, Brueckmann Martina, Blatchford Jonathan, Salsali Afshin, Ponikowski Piotr. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure. Nature Medicine, 2022, 28 (3), pp.568-574. ⟨10.1038/s41591-021-01659-1⟩
Title
  • The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure
dc:date
  • 2022
Digital Object Identifier (DOI)
  • 10.1038/s41591-021-01659-1
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software